As shown by representative Western blots in Figure 2A, ASMCs of COPD patients showed a higher expression of p62 (481.8%) and Beclin-1 (285.3%), as well as an increased ratio of LC3A/B II to LC3A/B I (198.2%) when compared with the control. Here, MAP1LC3A is linked to chronic obstructive pulmonary disease.